Sharing, analysing and interrogating data to make it meaningful is crucial. Yet much of the world’s most powerful software can be a nightmare to integrate and often requires in-depth, expensive training to enable you to use all those vital features…
Why the world needs to get real about how we treat data for INDs It goes without saying that preclinical collaboration is complex business. So why then is so much of the historical data, collected over so many years of…
The externalisation train has left the station. Whether we know it or not we are all on it. Academics, biotechs and SMEs have laid the tracks for major companies to travel through multiple international collaborations; accessing talent and making sure…
Funding cuts for academia and continuing issues for the pharmaceutical industry are causing considerable stress in life sciences and healthcare research. However, new opportunities are developing to enable industry to access high quality, longitudinal patient and genetic data for…
It’s encouraging to see personalised medicine being featured front and centre in The Times today in the article by Mark Henderson. Making diagnosis and treatment decisions based on an individual’s genetic makeup seemed a long way off just a few years ago…
With the pace of technological change it is more relevant than ever to question not only how children are taught but also what they are taught. From simple adjustments like replacingcursive handwriting with typing, to deep questions over how learning itself is…